DV
Daniel van den Bergh
OtherActiveHealthcare technology investor at Endeavour Vision
64
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Daniel van den Bergh.
Investment Thesis & Strategy
Daniel van den Bergh, as a healthcare technology investor at Endeavour Vision, invests in various stages of companies within the healthcare, drug delivery, health & hospital services, health IT, and medical devices sectors. He likely seeks innovative companies with the potential for significant impact and growth within these areas.
Portfolio Companies
Selected investments from their portfolio of 64 companies
A
AtheroMed
Other · , 0
A
Arcxis Biotechnologies
Biotech · Seed, 0
H
Hemosphere
Healthcare · Seed, 0
C
CytoPherx
Biotech · Seed, 0
C
CareGuardian
Healthcare · Seed, 0
N
NextWeb
Other · Seed, 0
A
Arbor Surgical Technologies
Healthcare · Seed, 0
G
GluMetrics
Healthcare · Seed, 0
H
Health Catalyst
Other · , 0
G
Ginger
Other · , 0
V
Validic
Other · , 0
N
NextHealth Technologies
Other · , 0
Frequently Asked Questions
Daniel van den Bergh focuses on Series B stage investments.
Related Investors
Bill Coughran
San Francisco, United States · 104 deals
Dave Lambert
San Francisco, United States · 101 deals
Arun Mathew
San Francisco, United States · 99 deals
Ash Rust
San Francisco, United States · 96 deals
Alex Tran
San Francisco, United States · 95 deals
Randy Williams
San Francisco, United States · 95 deals